What analyst predict for AngioDynamics Inc NASDAQ:ANGO ?

1
467

What analyst predict for AngioDynamics Inc NASDAQ:ANGO ?

AngioDynamics Inc NASDAQ:ANGO

AngioDynamics Inc is expected to report earnings on 03/29/2018 before market open. The report will be for the fiscal Quarter ending Feb 2018. According to Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.2. The reported EPS for the same quarter last year was $0.19.

()
()

Chart

Overview of AngioDynamics Inc NASDAQ:ANGO

AngioDynamics history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.

Queensbury was chosen due to its location in the heart of “Catheter Valley,” an area in New York’s Adirondack Region named for its long history of catheter and other medical device manufacturing. Today, the Company has made its presence apparent far beyond Upstate New York with 1,400 employees worldwide at facilities in the United States, Europe and Asia. AngioDynamics is currently selling in more than 50 markets through direct sales and distributors.

Initially dedicated to the research and development of products used in interventional radiology, AngioDynamics began shipping product in the early 1990s. The Company soon became well established as a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. In May 2004 the Company became publicly traded on the NASDAQ stock exchange under the symbol ANGO.

Through acquisitions of companies such as RITA Medical Systems in January 2007, Oncobionic in May 2008, and the assets of Diomed in June 2008 and FlowMedica in January 2009, AngioDynamics now boasts a diverse product line that includes market-leading radiofrequency ablation and NanoKnife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products, venous products and targeted renal therapy products.

ANGO
Name
Change
% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Volume
Dividend Rate

1 COMMENT

  1. […] What analyst predict for AngioDynamics Inc NASDAQ:ANGO ? (stockmarketdaily.co) […]

Comments are closed.